GlassScriptPhysician profile
Ben Naghi
NPI 1528046125
$19,536.59
in general payments reported to CMS, 2019-2025
46 companies · $1,102 in 2025
The $1,102 reported for 2025 was more than what 91% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,390 · 2020: $662 · 2021: $1,620 · 2022: $1,276 · 2023: $789 · 2024: $12K · 2025: $1,102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Food and Beverage: $2,860 · Gift: $28.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,700.00 |
| Food and Beverage | $2,860.34 |
| Gift | $28.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Human Regenerative Technologies | $10,700.00 | 2024 | |
| Coloplast Corp | $1,743.75 | 2019-2021 | |
| Abbvie INC. | $751.57 | 2019-2023 | |
| Medtronic, INC. | $748.83 | 2021-2025 | Truclear, Ligasure |
| Biom'Up France Sas | $608.75 | 2020-2021 | |
| Lumenis Be INC | $489.01 | 2025 | M22 |
| Therapeuticsmd, INC. | $402.63 | 2019-2022 | |
| Ascend Therapeutics US, LLC | $377.29 | 2022-2024 | |
| Mayne Pharma Commercial LLC | $316.83 | 2021-2025 | |
| Astellas Pharma US INC | $286.58 | 2019-2024 | Veozah |
| Aspira Women'S Health INC | $262.99 | 2020-2024 | Ova1 |
| Sage Therapeutics, LLC | $239.10 | 2020-2025 | Zurzuvae |
| Agile Therapeutics, INC. | $232.98 | 2021-2024 | Twirla |
| Organon LLC | $232.42 | 2021-2024 | Nexplanon |
| Pfizer INC. | $227.13 | 2019-2025 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $162.98 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $158.93 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $154.15 | 2019-2025 | |
| Exeltis, USA INC. | $152.81 | 2020-2024 | Slynd |
| Myovant Sciences INC. | $137.06 | 2021-2022 | |
| Ethicon US, LLC | $129.47 | 2019-2024 | Vistaseal, Surgicel Nu-Knit |
| Hologic Sales and Service, LLC | $114.24 | 2022-2025 | Aptima, Thinprep 2000 Processor, Myosure Tissue Removal Device |
| Vertical Pharmaceuticals, LLC | $113.76 | 2019 | |
| Roche Diagnostics Corporation | $78.16 | 2019-2021 | |
| Baxter Healthcare | $73.24 | 2023-2024 | Perclot |
| Sumitomo Pharma America, INC. | $56.54 | 2025 | Gemtesa, Myfembree |
| Novo Nordisk INC | $56.08 | 2019-2023 | Wegovy |
| Minerva Surgical, INC | $49.86 | 2019-2023 | |
| Amag Pharmaceuticals, INC. | $47.46 | 2019-2020 | |
| Shield Therapeutics INC | $47.17 | 2023-2024 | Accrufer |
| Millicent US INC | $42.16 | 2024-2025 | Intrarosa, Femring |
| Evofem Biosciences, INC. | $31.11 | 2020 | |
| Coopersurgical, INC. | $29.87 | 2022-2023 | Paragard T 380a |
| Mylan Pharmaceuticals INC. | $29.87 | 2021 | |
| Horizon Therapeutics Plc | $28.96 | 2019-2020 | |
| Myriad Women'S Health, INC. | $27.64 | 2023 | Myrisk |
| Cepheid | $26.46 | 2025 | Genexpert |
| Supernus Pharmaceuticals, INC. | $25.85 | 2025 | Qelbree |
| Meditrina | $23.60 | 2024 | |
| Mycovia Pharmaceuticals, INC. | $23.54 | 2023 | Vivjoa |
| Exact Sciences Corporation | $19.60 | 2024 | Cologuard Collection Kit |
| Acella Pharmaceuticals, LLC | $17.40 | 2025 | NP Thyroid 60 |
| Smith+Nephew, INC. | $16.17 | 2025 | Stravix Pl |
| Lupin INC. | $16.07 | 2020 | |
| Medicem INC. | $13.70 | 2021 | |
| Duchesnay USA Incorporated | $12.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ben Naghi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.